OS Therapies IncorporatedOSTXNYSE
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank15
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
-75.82%
↓ 128% vs avg
Percentile
P15
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-33.27%
Historical baseline
PeriodValue
Q3 2025-75.82%
Q2 202525.48%
Q1 2025-51.26%
Q4 202429.85%
Q3 2024-284.12%
Q2 2024-37.32%
Q1 202426.33%
Q4 20230.62%
Q3 2023-5.47%
Q2 2023-94.09%
Q1 20230.00%
Q4 20220.00%
Q1 20220.00%
Q4 20210.00%